Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Image: A new study shows that an ultrasensitive blood test can detect immune signaling patterns associated with Sjögren’s disease more than a decade before diagnosis (Image Credit: 123RF)

Ultrasensitive Blood Test Detects Sjögren’s Signature Years Before Diagnosis

A blood test detects early immune signatures up to a decade before Sjögren’s disease diagnosis. More...
21 Jul 2026
Image: The assay is designed to concurrently detect HSV-1, HSV-2, VZV, and MPXV in a single test (Image Credit: Adobe Stock)

Multiplex PCR Test Differentiates Four Causes of Ulcerative Skin Lesions

Seegene USA’s Allplex HSV-1&2/VZV/MPXV Assay has received Emergency Use Authorization (EUA) from the U.S. FDA. More...
21 Jul 2026
Graphical Abstract: Changes in circulating tumor DNA during Ra-223 treatment reflect disease course in patients with bone-metastatic castration-resistant prostate cancer. (Image created by Masaki Shiota et al., Kyushu University, Fukuoka, Japan)

Blood Test Guides Patient Selection for Radiopharmaceutical Therapy in Prostate Cancer

A new blood-based tumor DNA test predicts which patients benefit from radium-223 and tracks response to guide treatment in real time. More...
21 Jul 2026
Image: The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples (Photo courtesy of Bruker)

Bruker Expands NGS Capabilities for Sepsis and Bloodstream Infections

Bruker Corporationhas acquired the DISQVER clinical metagenomics platform, expanding its next-generation sequencing infection detection portfolio. More...
21 Jul 2026
Image: The assay is designed to concurrently detect HSV-1, HSV-2, VZV, and MPXV in a single test (Image Credit: Adobe Stock)

Multiplex PCR Test Differentiates Four Causes of Ulcerative Skin Lesions

Seegene USA’s Allplex HSV-1&2/VZV/MPXV Assay has received Emergency Use Authorization (EUA) from the U.S. FDA. More...
21 Jul 2026
Image: Atypical clustering of myeloid progenitor cells called myeloblasts (white arrows), defined by their co-expression of CD34 (magenta) and CD117 (green), in a bone marrow biopsy tissue from a patient with MDS. (Image Credit: Dr. Sanjay Patel)

AI Bone Marrow Mapping Provides New Tool to Track Blood Cancer Severity

An AI approach measures disease severity from routine bone marrow images, improving classification and ongoing monitoring of MDS. More...
20 Jul 2026
Image Credit: Shutterstock

New Biomarker Helps Guide Combination Therapy for Treatment-Resistant Breast Cancer

New findings identify a biomarker of chemotherapy-resistant triple-negative breast cancer, helping guide targeted combination therapy. More...
20 Jul 2026
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Copyright © 2000-2026 Globetech Media. All rights reserved.